| Betsy Ann Moga, CFNP | |
|
610 30th Ave W, Alexandria, MN 56308-3426 | |
| (320) 763-5123 | |
| (320) 763-7883 |
| Full Name | Betsy Ann Moga |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 14 Years |
| Location | 610 30th Ave W, Alexandria, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932418035 | NPI | - | NPPES |
| 1932418035 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | R130240-6 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Knute Nelson Home Care | Alexandria, MN | Home health agency |
| Alomere Health | Alexandria, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Douglas County Hospital | 0648171413 | 101 |
News Archive
One of the key reasons why children are missed by immunization programs, particularly in developing countries where Médecins Sans Frontières (MSF) works, is that the products that we currently have in their present formulation are not well-suited to the places that have the most un-immunized children. These are the most challenging contexts to work in.
Virginia Commonwealth University researchers have discovered how an antibiotic works to modulate the activity of a neurotransmitter that regulates brain functions, which eventually could lead to therapies to treat Alzheimer's disease, Huntington's disease, epilepsy, stroke, dementia and malignant gliomas.
AIDS Healthcare Foundation, the largest global AIDS organization which operates free AIDS treatment clinics in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Eastern Europe, including 18 healthcare centers in California, Florida, and Washington, DC, has banned pharmaceutical sales representatives from Merck and Co. Pharmaceuticals, from calling on AHF's medical providers and staff in its US healthcare centers.
PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has announced plans for a Phase 2 clinical trial of PMX-60056 in interventional cardiology, and the establishment of a focused Heptagonist Clinical Advisory Board (CAB). PMX-60056 is a synthetic small-molecule designed to reverse the anticoagulant activity of heparin and low molecular weight heparins (LMWH).
› Verified 8 days ago
| Entity Name | Douglas County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164424305 PECOS PAC ID: 0648171413 Enrollment ID: O20040115000387 |
News Archive
One of the key reasons why children are missed by immunization programs, particularly in developing countries where Médecins Sans Frontières (MSF) works, is that the products that we currently have in their present formulation are not well-suited to the places that have the most un-immunized children. These are the most challenging contexts to work in.
Virginia Commonwealth University researchers have discovered how an antibiotic works to modulate the activity of a neurotransmitter that regulates brain functions, which eventually could lead to therapies to treat Alzheimer's disease, Huntington's disease, epilepsy, stroke, dementia and malignant gliomas.
AIDS Healthcare Foundation, the largest global AIDS organization which operates free AIDS treatment clinics in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Eastern Europe, including 18 healthcare centers in California, Florida, and Washington, DC, has banned pharmaceutical sales representatives from Merck and Co. Pharmaceuticals, from calling on AHF's medical providers and staff in its US healthcare centers.
PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has announced plans for a Phase 2 clinical trial of PMX-60056 in interventional cardiology, and the establishment of a focused Heptagonist Clinical Advisory Board (CAB). PMX-60056 is a synthetic small-molecule designed to reverse the anticoagulant activity of heparin and low molecular weight heparins (LMWH).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Betsy Ann Moga, CFNP 610 30th Ave W, Alexandria, MN 56308-3426 Ph: (320) 763-5123 | Betsy Ann Moga, CFNP 610 30th Ave W, Alexandria, MN 56308-3426 Ph: (320) 763-5123 |
News Archive
One of the key reasons why children are missed by immunization programs, particularly in developing countries where Médecins Sans Frontières (MSF) works, is that the products that we currently have in their present formulation are not well-suited to the places that have the most un-immunized children. These are the most challenging contexts to work in.
Virginia Commonwealth University researchers have discovered how an antibiotic works to modulate the activity of a neurotransmitter that regulates brain functions, which eventually could lead to therapies to treat Alzheimer's disease, Huntington's disease, epilepsy, stroke, dementia and malignant gliomas.
AIDS Healthcare Foundation, the largest global AIDS organization which operates free AIDS treatment clinics in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Eastern Europe, including 18 healthcare centers in California, Florida, and Washington, DC, has banned pharmaceutical sales representatives from Merck and Co. Pharmaceuticals, from calling on AHF's medical providers and staff in its US healthcare centers.
PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has announced plans for a Phase 2 clinical trial of PMX-60056 in interventional cardiology, and the establishment of a focused Heptagonist Clinical Advisory Board (CAB). PMX-60056 is a synthetic small-molecule designed to reverse the anticoagulant activity of heparin and low molecular weight heparins (LMWH).
› Verified 8 days ago
Dr. Byron Howard Herdman, DNP, APRN, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 119 30th Ave W Ste 119, Alexandria, MN 56308 Phone: 320-762-6226 | |
Rachel Lee Arickx, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 610 30th Ave W, Alexandria, MN 56308 Phone: 320-763-2540 Fax: 320-763-5749 | |
Alisha Mae Colby-timm, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1610 8th Ave E, Alexandria, MN 56308 Phone: 320-335-6201 | |
Heather Renee Lucken Scholl, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 610 30th Ave W, Alexandria, MN 56308 Phone: 320-763-2540 | |
Megan Larsen, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1527 Broadway St, Alexandria, MN 56308 Phone: 320-762-0399 | |
Julia Fiecke, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 305 30th Ave W, Alexandria, MN 56308 Phone: 320-460-8028 Fax: 320-460-8029 | |
Andrea Tacheny, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1610 8th Ave E, Alexandria, MN 56308 Phone: 651-417-4966 |